Abstract The rising of a highly aggressive subtype of castration-resistant prostate cancer (CRPC) named treatment-induced neuroendocrine prostate cancer (t-NEPC) after androgen deprivation therapy (ADT) is well known for its features of the neuroendocrine differentiation (NED) and androgen receptor (AR) independence. However. t-NEPC is still largely unknown. Here. https://fitnessgravesyardes.shop/product-category/electronic-circuit-board/